Last reviewed · How we verify

NCT05926661

Support Tool for Families of High-Risk Children With Heart Disease During Hospital Admission and After Discharge

Withdrawn NA Last updated 19 September 2025
What this trial tests

NA trial testing NCC Support Toolkit in Heart Disease Congenital. Withdrawn.

Timeline
29 November 2023
Primary endpoint
30 April 2024
30 April 2024

Quick facts

Lead sponsorNemours Children's Clinic
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Start date29 November 2023
Primary completion30 April 2024
Estimated completion30 April 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nemours Children's Clinic

Who can join

18 and older, any sex, with Heart Disease Congenital. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to pilot the "support tool" in the Nemours Cardiac Center to assess acceptability and feasibility. This tool will be offered to 5 high-risk families, and they will be asked to complete a survey. In addition, healthcare providers including bed-side nurses and cardiologists will be asked to complete a survey to assess the feasibility of the tool.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Disease Congenital

Currently open trials in the same condition.

Other Nemours Children's Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05926661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing